Family functioning and psychological distress among Japanese breast cancer patients and families

2005 ◽  
Vol 13 (12) ◽  
pp. 1044-1050 ◽  
Author(s):  
Shuichi Ozono ◽  
Toshinari Saeki ◽  
Shinichi Inoue ◽  
Tomoyuki Mantani ◽  
Hitoshi Okamura ◽  
...  
2013 ◽  
Vol 8 (1) ◽  
pp. 301-311
Author(s):  
Naoko Nagai ◽  
Takashi Morimoto ◽  
Takashi Nomura ◽  
Yo Sasaki ◽  
Osamu Honda

2020 ◽  
Vol 19 ◽  
pp. 153473542093845
Author(s):  
Ke Ding ◽  
Xiuqing Zhang ◽  
Jingjing Zhao ◽  
He Zuo ◽  
Ziran Bi ◽  
...  

Objective: To evaluate the effectiveness and feasibility of Managing Cancer and Living Meaningfully (CALM), which is used to reduce chemotherapy-related cognitive impairment (CRCI), relieve psychological distress, and improve quality of life (QOL) in Chinese breast cancer survivors (BCs). Methods: Seventy-four BCs were enrolled in this study. All patients were randomly assigned to either the CALM group or the care as usual (CAU) group. All patients were evaluated by the Functional Assessment of Cancer Therapy–Cognitive Function (FACT-Cog), Distress Thermometer (DT), and the Functional Assessment of Cancer Therapy–Breast (FACT-B) before and after CALM or CAU application to BCs with CRCI. We compared the differences in all these scores between the CALM group and the control group and analyzed the correlation between cognitive function and QOL. Results: Compared with the CAU group, the performance of the CALM group on the FACT-Cog, DT, and FACT-B showed significant differences before and after CALM ( t = −18.909, −5.180, −32.421, P = .000, .000, .000, respectively). Finally, there was a positive correlation between cognitive function and QOL in breast cancer patients before ( r = 0.579, P = .000) and after ( r = 0.797, P = .000) treatment. Conclusions: The present results indicated that CALM has salutary effects on the improvement of cognitive impairment and QOL and relieves psychological distress in breast cancer patients, which may be due to a positive correlation between psychological distress and cognitive function or QOL.


2019 ◽  
Vol 10 ◽  
Author(s):  
Jochen Kaiser ◽  
Jörg Dietrich ◽  
Miena Amiri ◽  
Isa Rüschel ◽  
Hazal Akbaba ◽  
...  

The Breast ◽  
2017 ◽  
Vol 31 ◽  
pp. 26-33 ◽  
Author(s):  
Soufiane Berhili ◽  
Selma Kadiri ◽  
Amal Bouziane ◽  
Abdallah Aissa ◽  
Elamin Marnouche ◽  
...  

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Catharina Bartmann ◽  
Leah-Maria Fischer ◽  
Theresa Hübner ◽  
Max Müller-Reiter ◽  
Achim Wöckel ◽  
...  

Abstract Background The majority of breast cancer patients are severely psychologically affected by breast cancer diagnosis and subsequent therapeutic procedures. The COVID-19 pandemic and associated restrictions on public life have additionally caused significant psychological distress for much of the population. It is therefore plausible that breast cancer patients might be particularly susceptible to the additional psychological stress caused by the pandemic, increasing suffering. In this study we therefore aimed to assess the level of psychological distress currently experienced by a defined group of breast cancer patients in our breast cancer centre, compared to distress levels pre-COVID-19 pandemic. Methods Female breast cancer patients of all ages receiving either adjuvant, neoadjuvant, or palliative therapies were recruited for the study. All patients were screened for current or previous COVID-19 infection. The participants completed a self-designed COVID-19 pandemic questionnaire, the Stress and Coping Inventory (SCI), the National Comprehensive Cancer Network® (NCCN®) Distress Thermometer (DT), the European Organization for Research and Treatment of Cancer (EORTC) QLQ C30, and the BR23. Results Eighty-two breast cancer patients were included. Therapy status and social demographic factors did not have a significant effect on the distress caused by the COVID-19 pandemic. The results of the DT pre and during COVID-19 pandemic did not differ significantly. Using the self-designed COVID-19 pandemic questionnaire, we detected three distinct subgroups demonstrating different levels of concerns in relation to SARS-CoV-2. The subgroup with the highest levels of concern reported significantly decreased life quality, related parameters and symptoms. Conclusions This monocentric study demonstrated that the COVID-19 pandemic significantly affected psychological health in a subpopulation of breast cancer patients. The application of a self-created “COVID-19 pandemic questionnaire” could potentially be used to help identify breast cancer patients who are susceptible to increased psychological distress due to the COVID-19 pandemic, and therefore may need additional intensive psychological support. Trial registration DRKS-ID: DRKS00022507.


2011 ◽  
Vol 34 (4) ◽  
pp. E21-E30 ◽  
Author(s):  
Christina D. Wagner ◽  
Lala Tanmoy Das ◽  
Silvia M. Bigatti ◽  
Anna Maria Storniolo

Sign in / Sign up

Export Citation Format

Share Document